These injections, initially approved for treating blood sugar , have seen increased use due to their impact on weight management. Semaglutide (brand name copyright) is a version of the active ingredient, https://companyspage.com/story6450270/semaglutide-the-glp-1-receptor-agonists-a-quick-guide